<DOC>
	<DOCNO>NCT01439178</DOCNO>
	<brief_summary>Purpose : To evaluate acute change intraocular cytokine intravitreal bevacizumab ( IVB ) proliferative diabetic retinopathy . Design : Prospective , open-label , control , randomize interventional clinical trial . Participants : Twenty eye 28 consecutive patient schedule par plana vitrectomy ( ppV ) proliferative diabetic retinopathy prospectively enrol . Methods : All patient randomly assign receive IVB either 2 7 day ppV . Aqueous humor sample take anterior chamber IVB time surgery . Multiplex cytokine array use assay various cytokine</brief_summary>
	<brief_title>Acute Changes Intraocular Cytokines After Intravitreal Bevacizumab</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Complications</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Patients proliferative diabetic retinopathy schedule PPV vitreous hemorrhage tractional retinal detachment ( TRD ) Eyes pharmacologic intervention study eye within 6 month Eyes panretinal photocoagulation study eye within 3 month Eyes pharmacologic intervention fellow eye within 3 month , History ocular disease diabetic retinopathy History PPV study eye History systemic thromboembolic event include myocardial infarction cerebrovascular accident .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>